1. Home
  2. PIM vs BDSX Comparison

PIM vs BDSX Comparison

Compare PIM & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PIM
  • BDSX
  • Stock Information
  • Founded
  • PIM 1988
  • BDSX 2005
  • Country
  • PIM United States
  • BDSX United States
  • Employees
  • PIM N/A
  • BDSX N/A
  • Industry
  • PIM Finance Companies
  • BDSX Precision Instruments
  • Sector
  • PIM Finance
  • BDSX Health Care
  • Exchange
  • PIM Nasdaq
  • BDSX Nasdaq
  • Market Cap
  • PIM 159.3M
  • BDSX 189.1M
  • IPO Year
  • PIM N/A
  • BDSX 2020
  • Fundamental
  • Price
  • PIM $3.29
  • BDSX $1.40
  • Analyst Decision
  • PIM
  • BDSX Strong Buy
  • Analyst Count
  • PIM 0
  • BDSX 4
  • Target Price
  • PIM N/A
  • BDSX $3.08
  • AVG Volume (30 Days)
  • PIM 57.5K
  • BDSX 648.1K
  • Earning Date
  • PIM 01-01-0001
  • BDSX 11-01-2024
  • Dividend Yield
  • PIM 8.28%
  • BDSX N/A
  • EPS Growth
  • PIM N/A
  • BDSX N/A
  • EPS
  • PIM 0.05
  • BDSX N/A
  • Revenue
  • PIM N/A
  • BDSX $65,562,000.00
  • Revenue This Year
  • PIM N/A
  • BDSX $46.97
  • Revenue Next Year
  • PIM N/A
  • BDSX $30.43
  • P/E Ratio
  • PIM $63.80
  • BDSX N/A
  • Revenue Growth
  • PIM N/A
  • BDSX 48.92
  • 52 Week Low
  • PIM $2.90
  • BDSX $1.11
  • 52 Week High
  • PIM $3.28
  • BDSX $2.21
  • Technical
  • Relative Strength Index (RSI)
  • PIM 47.69
  • BDSX 49.86
  • Support Level
  • PIM $3.29
  • BDSX $1.24
  • Resistance Level
  • PIM $3.34
  • BDSX $1.40
  • Average True Range (ATR)
  • PIM 0.03
  • BDSX 0.09
  • MACD
  • PIM 0.00
  • BDSX 0.01
  • Stochastic Oscillator
  • PIM 54.17
  • BDSX 54.39

About PIM Putnam Master Intermediate Income Trust

Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: